[1]
R. Collins, R. Peto, S. MacMahon, P. Hebert, N.H. Fiebach, K.A. Eberlein, J. Godwin, N. Qizilbash, J.O. Taylor, C.H. Hennekens, Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context, Lancet. 335 (1990).
DOI: 10.1016/0140-6736(90)90944-z
Google Scholar
[2]
D.V. Preobrazhenskiy, B.A. Sidorenko, E.M. Nosenko, Ju.V. Prelatova, Brain as target organ in patients with AH and antihypertensive therapy, Cardiology (in Russian). 1 (2000) 83-88.
Google Scholar
[3]
O.D. Ostroumova, I.V. Desnitskaya, Approaches to the treatment of AH in hospital: the correction of blood pressure and cognitive function, Сonsilium medicum: 2 appendix (in Russian). (2005) 14-17.
Google Scholar
[4]
Z.A. Suslina, L.A. Geraskina, A.V. Fonyakin, Arterial hypertension, vascular pathology of the brain and antihypertensive treatment, Mediagraphiks, Moscow, 2006 (in Russian).
Google Scholar
[5]
G.Y.H. Lip, C.R. Gibbs, D.G. Beevers, Ambulatory blood pressure monitoring and stroke: more questions than answers, Stroke. 29 (1998) 1495-1497.
DOI: 10.1161/01.str.29.8.1495
Google Scholar
[6]
I. Yu. Efimova, I.A. Astanina, M.V. Kolodina, Cerebral microcirculation and structural changes in the brain with essential hypertension, Clin. Med. (in Russian). 12 (2004) 16 -19.
Google Scholar
[7]
F. Nobili, G. Rodriguez, S. Marenco, F. De Carli, M. Gambaro, C. Castello, R. Pontremoli, G. Rosadini, Regional cerebral blood flow in chronic hypertension. A correlative study, Stroke, 24, 8 (1993) 1148-1153.
DOI: 10.1161/01.str.24.8.1148
Google Scholar
[8]
N.R. Cutler, J.J. Sramek, A. Luna, I. Mena, E.P. Brass, N.M. Kurtz, J.J. Brennan, Effect of the ACE inhibitor ceronapril on cerebral blood flow in hypertensive patients, Ann. Pharmacother. 30(6) (1996) 578-582.
DOI: 10.1177/106002809603000601
Google Scholar
[9]
N.A. Lassen, A.R. Andersen, L. Fribrg, O.B. Paulson, The Retention of [99m-Tc]-d, l, -HMPAO in the Human Brain after Intracarotid Bolus injection: A Kinetic Analisis, J. Cerebral Blood Flow & Metab. 8 (1988) 13-22.
DOI: 10.1038/jcbfm.1988.28
Google Scholar
[10]
Y. Yonekura, S. Nishizawa, T. Mukai, SPECT with 99m-Tc- d, l – hexamethyl propylene amine oxime (HM-PAO) compared with regional cerebral blood flow measured by PET. Effects of linearization, J. Cerebral Blood Flow & Metab. 8 (1988) 82-89.
DOI: 10.1038/jcbfm.1988.36
Google Scholar
[11]
H.A.J. Struijker Boudier, J.L.M.L. Le Noble, M.W.J. Messing, M.S. Huijberts , F.A. le Noble, H. van Essen, The microcirculation and hypertension, J Hypertens. 10, 7 (1992) 147-156.
DOI: 10.1097/00004872-199212000-00016
Google Scholar
[12]
B.I. Levy, G. Ambrosio, A.R. Pries, H.A. Struijker-Boudier, Microcirculation in hypertension: a new target for treatment? Circulation. 104(6) (2001) 735-740.
DOI: 10.1161/hc3101.091158
Google Scholar
[13]
I.E. Chazova, V.B. Mychka, V.V. Gornostaev, I.M. Dvoskina, V.B. Sergienko, Cerebrovascular complications in patients with arterial hypertension: primary and secondary prevention, Сonsilium Medicum (in Russian). 5, 2 (2003) 3-6.
DOI: 10.18705/1607-419x-2003-9-5-160-163
Google Scholar
[14]
V.B. Mychka, V.B. Sergienko, V.V. Gornostaev, I.M. Dvoskina, I.E. Chazova, Effect of bisoprolol on cerebral perfusion in patients with metabolic syndrome, Arterial hypertension (in Russian). 9(5) (2003) 151-154.
DOI: 10.18705/1607-419x-2003-9-5-160-163
Google Scholar
[15]
D. Knopman, L.L. Boland, T. Mosley, G. Howard, D. Liao, M. Szklo, P. McGovern, A.R. Folsom, Cardiovascular risk factors and cognitive decline in middle-aged adults, Neurology. 56 (2001) 42-48.
DOI: 10.1212/wnl.56.1.42
Google Scholar
[16]
O.D. Ostroumova, N.K. Korsakova, Ju.A. Bagramova, N.A. Varako, Arterial hypertension and vascular dementia: the influence of antihypertensive therapy on cognitive function in elderly patients (clinical and pharmacoeconomic aspects), Сonsilium Medicum (in Russian). 5 (2003).
Google Scholar